Luke McLaughlin: Haemophilia Care as a Matter of Global Health Equity
Luke McLaughlin, Founder of The Haemophilia Rights Project, shared World Federation of Hemophilia‘s post on LinkedIn, adding:
“The significance of this milestone should not be understated.
The advancement of medical treatments in Haemophilia can only be seen as revolutionary if they are equally distributed around the globe.
No human should be too expensive or inconvenient to treat. Cost should never be an excuse to disregard human rights.
I commend Armenia, World Federation of Hemophilia and the unilateral coalition of supporting states for highlighting treatment equity in Haemophilia at the highest international level.
Treatment should be a right for all people with Haemophilia and bleeding disorders.”
World Federation of Hemophilia (WFH) shared a post on LinkedIn:
“Today marks a historic milestone for the global Bleeding Disorders community.
The 79th World Health Assembly has adopted the resolution on ‘Global action to advance health equity for people with hemophilia and other bleeding disorders.’
This landmark adoption recognizes the urgent need to improve diagnosis, access to treatment, comprehensive care, and health equity for people living with bleeding disorders around the world.
It signals commitment by the WHO and Member States to advance these priorities.
Watch the address of Cesar Garrido, the WFH President, at the WHA79.
The World Federation of Hemophilia extends its sincere gratitude to Armenia for its leadership, as well as to all co-sponsoring Member States – in addition to all the partners, advocates, healthcare professionals, national member organizations, and community members whose collaboration helped make this possible, including over 100 organizations that joined the WFH’s Global Call for Health Equity for Bleeding Disorders.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment